| abstract |
This invention relates to the therapeutic administration of a compound of formula (IIb):n nwherein nR 7b is a member selected from H, methyl, ethyl and phenyl; nR 10b is a member selected from H, OH, NH 2 , SH, halogen, substituted or unsubstituted phenoxy, substituted or unsubstituted phenylalkyloxy, substituted or unsubstituted phenylthio and substituted or unsubstituted phenylalkylthio; and nR 11b is a member selected from H, OH, NH 2 , SH, methyl, substituted or unsubstituted phenoxy, substituted or unsubstituted phenylalkyloxy, substituted or unsubstituted phenylthio and substituted or unsubstituted phenylalkylthio wherein the term "alkyl" is a C 1 -C 10 alkyl group; nand to pharmaceutical formulations of such compounds. |